Edition:
United States

People: Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.98USD
4:00pm EDT
Change (% chg)

$0.03 (+3.16%)
Prev Close
$0.95
Open
$0.95
Day's High
$0.98
Day's Low
$0.85
Volume
209,905
Avg. Vol
445,276
52-wk High
$12.12
52-wk Low
$0.66

Hendrick, Edwin 

Mr. Edwin C. Hendrick is Senior Vice President, Chief Commercial Officer of the Company. Mr. Hendrick has achieved a strong track record of building and growing businesses during a distinguished career spanning over 25 years in healthcare. He has led commercial operations within diagnostic and healthcare service companies ranging in size from$10 millionto$1 billionin revenues. In his most recent position at GenomeDx, he developed the company's commercial strategy and launched its commercial offering. Mr. Hendrick engaged with every department in moving the company from the start-up phase to a commercial-ready organization. Prior to GenomeDx, in his role as Executive Vice President, Sales and Marketing of PLUS Diagnostics, Mr. Hendrick led the company's transformation from a regional laboratory generating$10 millionin annual revenues to a national anatomic pathology leader achieving more than$100 millionin annual revenues. PLUS Diagnostics' growth culminated in the company's successful sale to Miraca Life Sciences inOctober 2013, now Inform Diagnostics. Mr. Hendrick also served as an executive with US Labs, a start-up anatomic pathology company. He helped build the company's operations, sales and marketing organizations which ended in its purchase by LabCorp in 2005. Prior to US Labs, Mr. Hendrick led sales and marketing for Ventana Medical Systems, a medical device and reagent business, now a member of the Roche Group. Mr. Hendrick began his career in sales for Abbott Laboratories, and received his Bachelor of Arts in Advertising from the University of Kentucky.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Hale

940,712

Michael Nall

1,139,840

Timothy Kennedy

622,437

Lyle Arnold

550,676

Edwin Hendrick

--

Michael Terry

--
As Of  30 Dec 2017